Treatment of irritable bowel syndrome: beyond fiber and antispasmodic agents

Por Sainsbury, Anita, Ford, Alexander C.
Publicado em 2011

Initial management of dyspepsia in primary care: an evidence-based approach

Por Ansari, Saqib, Ford, Alexander C
Publicado em 2013

Linaclotide: new mechanisms and new promise for treatment in constipation and irritable bowel syndrome

Por Sood, Ruchit, Ford, Alexander C.
Publicado em 2013

Constipation in adults

Por Lau, Michelle, Ford, Alexander C.
Publicado no BMJ Clin Evid (2015)

Use of Biomarkers in Irritable Bowel Syndrome: To Predict the Future, Look at the Past

Por Sood, Ruchit, Ford, Alexander C
Publicado no Clin Transl Gastroenterol (2015)

Pharmacotherapy for Irritable Bowel Syndrome

Por Camilleri, Michael, Ford, Alexander C.
Publicado no J Clin Med (2017)

IBS-like symptoms in patients with ulcerative colitis

Por Gracie, David J, Ford, Alexander C
Publicado no Clin Exp Gastroenterol (2015)

Prevalence of functional gastrointestinal disorders among consecutive new patient referrals to a gastroenterology clinic

Por Shivaji, Uday N, Ford, Alexander C
Publicado no Frontline Gastroenterol (2014)

Young GI angle: How to approach evidence-based medicine

Por Eusebi, Leonardo H, Ford, Alexander C
Publicado no United European Gastroenterol J (2018)

Making a positive diagnosis of irritable bowel syndrome

Por Sood, Ruchit, Foy, Robbie, Ford, Alexander C
Publicado no Br J Gen Pract (2017)

Cyclic vomiting syndrome: a case series and review of the literature

Por Shearer, Jessica, Luthra, Pavit, Ford, Alexander C
Publicado no Frontline Gastroenterol (2018)

Multiple myeloma presenting in association with gastric phytobezoar

Por Appleton, Elizabeth S., Lee, Natasha A., Ford, Alexander C.
Publicado no Clin Case Rep (2017)

Fatigue and its associated factors in microscopic colitis

Por Kane, John S., Irvine, Andrew J., Derwa, Yannick, Ford, Alexander C.
Publicado no Therap Adv Gastroenterol (2018)

Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials

Por Ford, Alexander C, Forman, David, Hunt, Richard H, Yuan, Yuhong, Moayyedi, Paul
Publicado em 2014

Ipilimumab-induced colitis: experience from a tertiary referral center

Por O’Connor, Anthony, Marples, Maria, Mulatero, Clive, Hamlin, John, Ford, Alexander C.
Publicado no Therap Adv Gastroenterol (2016)

High prevalence of irritable bowel syndrome-type symptoms in microscopic colitis: implications for treatment

Por Kane, John S., Irvine, Andrew J., Derwa, Yannick, Rotimi, Olorunda, Ford, Alexander C.
Publicado no Therap Adv Gastroenterol (2018)

The Effect of Antidepressants on the Course of Inflammatory Bowel Disease

Por Hall, Barry J., Hamlin, P. John, Gracie, David J., Ford, Alexander C.
Publicado no Can J Gastroenterol Hepatol (2018)

Initial poor quality of life and new onset of dyspepsia: results from a longitudinal 10‐year follow‐up study

Por Ford, Alexander C, Forman, David, Bailey, Alastair G, Axon, Anthony T R, Moayyedi, Paul
Publicado em 2007

Adverse events with bismuth salts for Helicobacter pylori eradication: Systematic review and meta-analysis

Por Ford, Alexander C, Malfertheiner, Peter, Giguère, Monique, Santana, José, Khan, Mostafizur, Moayyedi, Paul
Publicado em 2008

Efficacy of infliximab in acute severe ulcerative colitis: A single-centre experience

Por Halpin, Stephen J, Hamlin, P John, Greer, Daniel P, Warren, Lisa, Ford, Alexander C
Publicado em 2013